Table 4 Administration of radiochemotherapy
Dose level | ||||
|---|---|---|---|---|
1 | 2 | 3 | Total | |
Number of patients | 4 (100%) | 13 (100%) | 7 (100%) | 24 (100%) |
Chemotherapy delay? | ||||
No | 3 (75%) | 5 (38%) | 5 (71%) | 13 (54%) |
Yes | 1 (25%) | 8 (62%) | 2 (29%) | 11 (46%) |
If yes, reason for delay: | ||||
Administrative reason | 1 (100%) | 4 (50%) | 1 (50%) | 6 (55%) |
Adverse event | 4 (50%) | 1 (50%) | 5 (45%) | |
Chemotherapy reduction? | ||||
No | 3 (75%) | 11 (85%) | 6 (86%) | 20 (83%) |
Yes | 1 (25%) | 2 (15%) | 1 (14%) | 4 (17%) |
If so, reason for reduction: | ||||
Administrative reason | 1 (50%) | 1 (25%) | ||
Adverse event | 1 (100%) | 1 (50%) | 1 (100%) | 3 (75%) |
Radiotherapy total dose (Gy) | ||||
Mean (SD) | 46.8 (4.41) | 44.45 (10.68) | 46.54 (2.63) | 45.45 (8.07) |
Median (range) | 47.7 (41.4–50.4) | 45.0 (10.8–50.4) | 45.0 (45.0–50.4) | 45.0 (10.8–50.4) |